Viatris, Inc. (VTRS)
13.21
-0.03
(-0.23%)
USD |
NASDAQ |
Jan 23, 16:00
13.20
-0.01
(-0.08%)
After-Hours: 20:00
Viatris Cash from Investing (Quarterly): -98.90M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Pfizer Inc. | -2.43B |
| Boston Scientific Corp. | -502.00M |
| Amgen, Inc. | -414.00M |
| Moderna, Inc. | 700.00M |
| BioCryst Pharmaceuticals, Inc. | 13.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 744.90M |
| Cash from Financing (Quarterly) | -228.10M |
| Free Cash Flow | 1.614B |
| Free Cash Flow Per Share (Quarterly) | 0.554 |
| Free Cash Flow to Equity (Quarterly) | 688.30M |
| Free Cash Flow to Firm (Quarterly) | 2.610B |
| Free Cash Flow Yield | 10.35% |